Clinical Trials Directory

Trials / Completed

CompletedNCT03397849

Lifestyle Intervention Using Mobile Technology in Patients With High Cardiovascular Risk

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
320 (actual)
Sponsor
Ministry of Health, Turkey · Other Government
Sex
All
Age
20 Years – 79 Years
Healthy volunteers
Not accepted

Summary

In the present study, investigators aim to compare intervention using mobile technology (IMT) plus usual care with only usual care in patients with a high risk for cardiovascular diseases (CVD). Investigators hypothesize that IMT plus usual care reduces the CVD risk and improves the secondary outcomes in this population through 12 months of follow-up period. Patients presented to the outpatient clinics in a tertiary hospital (Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Research and Training Hospital, Istanbul, Turkey) who were considered to be eligible according to inclusion and exclusion criteria will be enrolled to the study. The eligibility criteria is; Patients between 20 to 79 years old who are in high risk for CVD (10 years ASCVD risk ≥ 7.5%). Patients with prior CVD events (myocardial infarction, percutaneous coronary intervention, coronary artery by-pass grafting operation, stroke and peripheral artery disease), pregnancy, communication problems, severe neuropsychiatric problems and chronic kidney disease are excluded from the study. In addition, patients that are unable to use smartphone phone are also excluded.

Conditions

Interventions

TypeNameDescription
BEHAVIORALIntervention using mobile technologyEach study patients that are randomized to IMT plus usual care group will receive a group of smart devices including mobile phone (Vestel Venus e2) (Vestel, Manisa, Turkey), wristband (Xiaomi band 2) (Beijing Xiaomi Technology Co., Beijing, China), weight scale (Bluecat, Yongkang Tiansheng Electronic Co., Zhejiang, China) and blood pressure monitor (Clever Chek TD-3250) (TaiDoc Technology Co., Taipei County, Taiwan)

Timeline

Start date
2018-02-01
Primary completion
2020-03-01
Completion
2020-03-01
First posted
2018-01-12
Last updated
2020-04-21

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03397849. Inclusion in this directory is not an endorsement.